Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06324981 · ClinicalTrials.gov registry record · NA

Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors

A NA study of Cardiovascular Diseases and Lifestyle Factors, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
2,100
Enrollment target
3
Study locations

NCT06324981 is a NA study of Cardiovascular Diseases and Lifestyle Factors that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 2,100 participants, below the 26,967-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (92% lower). The trial reports 3 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06324981, a NA study of Cardiovascular Diseases and Lifestyle Factors, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
2,100 participants
Enrollment target
3
Study locations

Study Summary

The goal of our pragmatic clinical trial is to compare how well three different strategies might do to reduce risk factors for cardiovascular disease in patients experiencing health disparities. The three different strategies are: 1) text messages, 2) interactive chatbot messages, and 3) chatbot messages with proactive pharmacist support. To measure cardiovascular risk factors, the investigators are using the American Heart Association's Life's Essential 8 (LE8) factors-blood glucose, cholesterol, blood pressure, physical activity, body mass index, diet, and smoking. This study focuses on improving cardiovascular risk factors for individuals facing health disparities, such as ethnic minorities, limited English proficiency, and low-income groups. These groups are more likely to be seriously affected by cardiovascular diseases. Self-management, or an individual's roles in managing their own chronic disease, includes lifestyle changes, medication adherence. Improving patients' self-management has been shown to improve health behaviors, better disease control and improved patient outcomes. The main question this study aims to answer is if one of the strategies (texting, chatbot, or chatbot with pharmacist support) may improve patient self-management and patient outcomes. The investigators will enroll up to 2,100 patients from three health systems that serve large populations experiencing health disparities: Denver Health, Salud Family Health Centers, and STRIDE Community Health Center. The results might help researchers and health care systems find the best ways to involve patients with health disparities to managing their chronic cardiovascular disease.

Interventions

  • BEHAVIORAL Generic text messages
  • BEHAVIORAL Interactive AI chatbot text messaging
  • BEHAVIORAL Proactive pharmacist support

Study Locations (3)

Colorado

  • Denver Health - Denver
  • Salud Family Health Centers - Fort Lupton
  • STRIDE Community Health Centers - Wheat Ridge

Trial Details

FieldValue
Enrollment Target 2,100 participants
Start Date 2024-02-26
Est. Completion 2028-06
Phase NA

Sponsor

University of Colorado, Denver

1,283 total trials

What the Registry Record Tells You About NCT06324981

The ClinicalTrials.gov registry entry for NCT06324981 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 2,100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 26,967-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (92% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 3 interventions - of which Generic text messages is the first listed.

NCT06324981 reports 3 study locations spanning 1 distinct geographic area - top geographies include Colorado.

Frequently Asked Questions

What is clinical trial NCT06324981 about?

NCT06324981 is a clinical study titled "Using AI Text Messaging to Improve AHA's Life's Essential 8 Health Behaviors". The goal of our pragmatic clinical trial is to compare how well three different strategies might do to reduce risk factors for cardiovascular disease in patients experiencing health disparities. The three different strategies are: 1) text messages, 2) interactive chatbot messages, and 3) chatbot mes...

What is the current status of trial NCT06324981?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,100 participants. The study started on 2024-02-26. Estimated completion is 2028-06.

What conditions does trial NCT06324981 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Lifestyle Factors.

What interventions are being tested in trial NCT06324981?

The interventions under investigation include: Generic text messages (BEHAVIORAL), Interactive AI chatbot text messaging (BEHAVIORAL), Proactive pharmacist support (BEHAVIORAL).

Who is sponsoring clinical trial NCT06324981?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06324981 being conducted?

This trial has 3 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.